blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0915911

EP0915911 - PARATHYROID HORMONE ANALOGUES FOR THE TREATMENT OF OSTEOPOROSIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.09.2004
Database last updated on 02.09.2024
Most recent event   Tooltip03.09.2004No opposition filed within time limitpublished on 20.10.2004  [2004/43]
Applicant(s)For all designated states
NATIONAL RESEARCH COUNCIL OF CANADA
Intellectual Property Services Office, Bldg. M-58. EG-12, Montreal Road Ottawa
Ontario K1A 0R6 / CA
[N/P]
Former [2003/22]For all designated states
National Research Council of Canada
Intellectual Property Services Office, Bldg. M-58. EG-12, Montreal Road
Ottawa, Ontario K1A 0R6 / CA
Former [1999/20]For all designated states
NATIONAL RESEARCH COUNCIL OF CANADA
Intellectual Property Services, EG-12, Bldg. M-58, Montreal Road
Ottawa, Ontario K1A 0R6 / CA
Inventor(s)01 / BARBIER, Jean-René
7 Beloeil Street
Gatineau, Quebec J8T 7G4 / CA
02 / MORLEY, Paul
777 Southmore Drive West
Ottawa, Ontario K1V 6Z9 / CA
03 / NEUGEBAUER, Witold
208 Provender Avenue
Ottawa, Ontario K1K 4N7 / CA
04 / WHITFIELD, James
621 Manfield Avenue
Ottawa, Ontario K2A 2T3 / CA
05 / WILLICK, Gordon, E.
1950 Kimball Court
Orleans, Ontario K1C 7C1 / CA
 [2003/12]
Former [1999/20]01 / BARBIER, Jean-René
7 Beloeil Street
Gatineau, Quebec J8T 7G4 / CA
02 / MORLEY, Paul
777 Southmore Drive West
Ottawa, Ontario K1V 6Z9 / CA
03 / NEUGEBAUER, Witold
208 Provender Avenue
Ottawa, Ontario K1K 4N7 / CA
04 / ROSS, Virginia
4611 Carrington Street
Gloucester, Ontario K1B 4R1 / CA
05 / WHITFIELD, James
621 Manfield Avenue
Ottawa, Ontario K2A 2T3 / CA
06 / WILLICK, Gordon, E.
1950 Kimball Court
Orleans, Ontario K1C 7C1 / CA
Representative(s)Perry, Robert Edward
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London
EC2A 2ES / GB
[N/P]
Former [1999/20]Perry, Robert Edward
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Application number, filing date97933603.901.08.1997
[1999/20]
WO1997CA00547
Priority number, dateUS1996069164702.08.1996         Original published format: US 691647
US19970040560P14.03.1997         Original published format: US 40560 P
[1999/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9805683
Date:12.02.1998
Language:EN
[1998/06]
Type: A1 Application with search report 
No.:EP0915911
Date:19.05.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 12.02.1998 takes the place of the publication of the European patent application.
[1999/20]
Type: B1 Patent specification 
No.:EP0915911
Date:29.10.2003
Language:EN
[2003/44]
Search report(s)International search report - published on:EP12.02.1998
ClassificationIPC:C07K14/635
[1999/20]
CPC:
A61K38/29 (EP); C07K14/635 (EP,KR); A61P19/00 (EP);
A61P19/10 (EP); A61P5/14 (EP); A61P5/20 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   NL,   PT,   SE [1999/20]
TitleGerman:ANALOGE DES PARATHORMONS ZUR BEHANDLUNG DER OSTEOPOROSE[1999/20]
English:PARATHYROID HORMONE ANALOGUES FOR THE TREATMENT OF OSTEOPOROSIS[1999/20]
French:ANALOGUES DE LA PARATHORMONE DESTINES AU TRAITEMENT DE L'OSTEOPOROSE[1999/20]
Entry into regional phase01.03.1999National basic fee paid 
01.03.1999Designation fee(s) paid 
01.03.1999Examination fee paid 
Examination procedure27.02.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.03.1999Examination requested  [1999/20]
01.03.1999Request for accelerated examination filed
16.11.1999Despatch of a communication from the examining division (Time limit: M04)
16.11.1999Decision about request for accelerated examination - accepted: Yes
24.02.2000Reply to a communication from the examining division
20.03.2000Despatch of a communication from the examining division (Time limit: M04)
19.07.2000Reply to a communication from the examining division
19.09.2000Despatch of a communication from the examining division (Time limit: M06)
22.03.2001Reply to a communication from the examining division
04.05.2001Despatch of a communication from the examining division (Time limit: M06)
06.11.2001Reply to a communication from the examining division
05.12.2001Despatch of a communication from the examining division (Time limit: M06)
31.05.2002Reply to a communication from the examining division
18.06.2002Despatch of a communication from the examining division (Time limit: M04)
17.10.2002Reply to a communication from the examining division
29.11.2002Communication of intention to grant the patent
19.03.2003Fee for grant paid
19.03.2003Fee for publishing/printing paid
Divisional application(s)EP02028170.5  / EP1352912
Opposition(s)30.07.2004No opposition filed within time limit [2004/43]
Fees paidRenewal fee
11.08.1999Renewal fee patent year 03
16.08.2000Renewal fee patent year 04
28.08.2001Renewal fee patent year 05
14.08.2002Renewal fee patent year 06
13.08.2003Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XDY]WO9306845  (PANG PETER K T [CA]) [XD] 47-50 * abstract * * example 1 * [Y] 1-46,51-54;
 [Y]GB2269176  (SANDOZ LTD [CH]) [Y] 1-46 * claim 1 * * the whole document *;
 [Y]WO9511988  (AFFYMAX TECH NV [NL], et al) [Y] 1-46* the whole document *;
 [XY]CA2126299  (WILLICK GORDON E [CA], et al) [X] 1-18 * the whole document * * figures 1-10; claims 1-3; table 1 * [Y] 19-46,51-54;
 [Y]  - T. KANMERA ET AL., "Conformationally constrained PTH-related protein antagonists", PEPTIDES. PROCEEDINGS OF THE 23TH EUROPEAN PEPTIDE SYMPOSIUM, (1994), pages 650 - 651, XP002049214 [Y] 1-46 * table 1 *
 [Y]  - NEUGEBAUER W ET AL, "STRUCTURE AND PROTEIN KINASE C STIMULATING ACTIVITIES OF LACTAM ANALOGUES OF HUMAN PARATHYROID HORMONE FRAGMENT", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, (19940601), vol. 43, no. 6, pages 555 - 562, XP000442516 [Y] 1-46 * page 558, paragraph 1 *
 [Y]  - CHOREV M ET AL, "CYCLIC PARATHYROID HORMONE RELATED PROTEIN ANTAGONISTS: LYSINE 13 TO ASPARTIC ACID 17 (I TO (I + 4)) SIDE CHAIN TO SIDE CHAIN LACTAMIZATION", BIOCHEMISTRY, (19910618), vol. 30, no. 24, pages 5968 - 5974, XP000206326 [Y] 1-46 * the whole document *

DOI:   http://dx.doi.org/10.1021/bi00238a022
 [Y]  - W.K. SUREWICZ, "Structure-function relationship in hPTH", PEPTIDES: CHEMISTRY, STRUCTURE AND BIOLOGY - PROCEEDINGS OF THE 13TH AMERICAN PEPTIDE SYMPOSIUM, (1993), XP002049215 [Y] 1-46 * page 558, paragraph 2; table 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.